|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | - |
| 13/11/18 | CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel | CI |
| 30/08/18 | Joe Pavlik Joins the Advisory Board of CaliPharms, Inc | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -99.00% | -.--% | - | - | - | - | - | - | - | 13.88K | ||
| +0.21% | +2.24% | +11.59% | -0.36% | -6.87% | -7.94% | -2.63% | -25.23% | +6.90% | 13.92B | ||
| +0.15% | +1.94% | +13.89% | -5.22% | -18.41% | -28.44% | -49.20% | -23.06% | -17.72% | 5.33B | ||
| -1.12% | +6.51% | +20.41% | -0.69% | +11.29% | +4.48% | +7.71% | +79.14% | -5.04% | 5.21B | ||
| +1.56% | -0.30% | +12.60% | -0.88% | -1.05% | +2.24% | -31.81% | -10.16% | +45.16% | 4.11B | ||
| -0.03% | +2.05% | +2.87% | -5.69% | -16.07% | +0.82% | -3.91% | +48.81% | +114.51% | 3.79B | ||
| -0.33% | -0.67% | +20.96% | -3.07% | +2.05% | -2.58% | -3.17% | +77.40% | -3.70% | 3.67B | ||
| +1.51% | +1.07% | +21.84% | +6.54% | +6.97% | -2.72% | +12.33% | +25.94% | -44.97% | 3.51B | ||
| +0.90% | -0.25% | +7.95% | -3.19% | +0.77% | -14.25% | -23.38% | -21.79% | - | 2.44B | ||
| -2.04% | +1.72% | +18.68% | +2.86% | +11.06% | -1.20% | +46.59% | +129.08% | +103.36% | 1.96B | ||
| +0.38% | +1.89% | +11.36% | -7.74% | -11.33% | -26.82% | -12.84% | -24.86% | -23.98% | 1.75B | ||
| +0.46% | +0.70% | +10.71% | -3.12% | -2.69% | -7.66% | -21.66% | +0.70% | -36.18% | 1.62B | ||
| +0.60% | +0.60% | +16.21% | -1.46% | -4.26% | -21.08% | -36.29% | -22.53% | -42.20% | 1.49B | ||
| +0.28% | +0.84% | +2.27% | -5.19% | -10.77% | -23.78% | +31.69% | +83.46% | +57.60% | 1.47B | ||
| -1.02% | +1.73% | +20.61% | -2.59% | -8.46% | -18.11% | -40.04% | -11.05% | -35.68% | 1.18B | ||
| +0.15% | +0.68% | +9.02% | -7.13% | -5.74% | -12.74% | -17.96% | +3.50% | -29.08% | 1.15B | ||
| +2.26% | -1.20% | +16.47% | -6.22% | +3.67% | -20.54% | -27.07% | -0.44% | -64.00% | 1.11B | ||
| -2.22% | 0.00% | -2.46% | +9.97% | +10.28% | +44.89% | +53.88% | -57.13% | +782.22% | 1.08B | ||
| +0.95% | +2.62% | +15.14% | -11.04% | -17.07% | -31.64% | -53.58% | -60.53% | -29.86% | 1.07B | ||
| +0.88% | +3.14% | +5.99% | -8.55% | +5.75% | -14.81% | -44.98% | -32.65% | -76.08% | 920M | ||
| Average | -4.77% | +1.67% | +12.43% | -2.78% | -2.68% | -9.57% | -11.39% | +8.35% | +38.96% | 2.84B | |
| Weighted average by Cap. | +0.18% | +2.38% | +13.22% | -1.89% | -3.62% | -8.21% | -9.54% | +9.46% | +21.07% |
- Stock Market
- Stocks
- KGET Stock
- Sector CaliPharms, Inc.
Select your edition
All financial news and data tailored to specific country editions
















